SKB BIO Announces Investment in Structured Deposit Product

Stock News
06/03

SKB BIO (HKEX: 06990) has disclosed a new financial transaction. On June 3, 2026, the company entered into the China Zheshang Bank Structured Deposit Agreement IV. Under this agreement, SKB BIO has agreed to subscribe for a structured deposit from China Zheshang Bank with a principal amount of RMB 300 million.

As of the date of this announcement, the total outstanding principal amount of the company's wealth management products placed with China Zheshang Bank stands at RMB 590 million. This total comprises three specific structured deposits: (i) a RMB 100 million deposit under Structured Deposit Agreement II, details of which were provided in an April 2026 announcement; (ii) a RMB 190 million deposit under Structured Deposit Agreement III; and (iii) the newly announced RMB 300 million deposit under Structured Deposit Agreement IV.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10